DrugDashboards

Amiodarone Hydrochloride

amiodarone hydrochloride · AMIODARONE HYDROCHLORIDE 50 mg/mL · Injection, Solution · Intravenous · Medical Purchasing Solutions, LLC.

NDC 71872-7354-01 · 1 VIAL in 1 BAG / 3 mL in 1 VIAL · ANDA · View full market →

The short version

14 companies supply this market — deep enough that no single failure threatens the supply. Historically, drugs in this position went on to a new shortage within 90 days about 0.5% of the time — roughly 4× the typical drug (0.1%).

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.5%chance of a new FDA shortage posting for amiodarone hydrochloride (injectable) in the next 90 days

sterile injectable · OAI inspection at a producing facility (24 months) · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is 4× that.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
ANDA218253
TE code
AP
Approval date
Sep 11, 2024
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of amiodarone hydrochloride (Injection, Solution)

LabelerStrengthFirst seenLast seen
Fresenius Kabi USA, LLCAMIODARONE HYDROCHLORIDE 50 mg/mLJul 15, 2026Sep 3, 2026
Medical Purchasing Solutions, LLCAMIODARONE HYDROCHLORIDE 50 mg/mLJul 15, 2026Sep 3, 2026
Zhejiang Poly Pharm. Co., Ltd.AMIODARONE HYDROCHLORIDE 50 mg/mLJul 15, 2026Sep 3, 2026
AuroMedics Pharma LLCAMIODARONE HYDROCHLORIDE 150 mg/3mLJul 15, 2026Sep 2, 2026
AuroMedics Pharma LLCAMIODARONE HYDROCHLORIDE 900 mg/18mLJul 15, 2026Sep 2, 2026
AuroMedics Pharma LLCAMIODARONE HYDROCHLORIDE 450 mg/9mLJul 15, 2026Sep 2, 2026
Baxter Healthcare CorporationAMIODARONE HYDROCHLORIDE 1.5 mg/mLJul 15, 2026Sep 2, 2026
Baxter Healthcare CorporationAMIODARONE HYDROCHLORIDE 1.8 mg/mLJul 15, 2026Sep 2, 2026
Gland Pharma LimitedAMIODARONE HYDROCHLORIDE 50 mg/mLJul 15, 2026Sep 2, 2026
Henry Schein, Inc.AMIODARONE HYDROCHLORIDE 50 mg/mLJul 15, 2026Sep 2, 2026
HF Acquisition Co LLC, DBA HealthFirstAMIODARONE HYDROCHLORIDE 50 mg/mLJul 15, 2026Sep 2, 2026
Hikma Pharmaceuticals USA Inc.AMIODARONE HYDROCHLORIDE 50 mg/mLJul 15, 2026Sep 2, 2026
Medical Purchasing Solutions, LLCAMIODARONE HYDROCHLORIDE 150 mg/3mLJul 15, 2026Sep 2, 2026
Medical Purchasing Solutions, LLC.AMIODARONE HYDROCHLORIDE 50 mg/mLJul 15, 2026Sep 2, 2026
ProPharma DistributionAMIODARONE HYDROCHLORIDE 50 mg/mLJul 15, 2026Sep 2, 2026
Remedyrepack Inc.AMIODARONE HYDROCHLORIDE 50 mg/mLJul 15, 2026Sep 2, 2026
Slate Run PharmaceuticalsAMIODARONE HYDROCHLORIDE 50 mg/mLJul 15, 2026Sep 2, 2026
Mylan Institutional LLCAMIODARONE HYDROCHLORIDE 50 mg/mLJul 15, 2026Aug 28, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Amiodarone Hydrochloride — NDC 71872-7354-01," retrieved September 3, 2026, https://drugdashboards.com/drug/71872735401.

Free to cite with attribution — see how the data is put together.